首页 | 本学科首页   官方微博 | 高级检索  
     

肿瘤免疫治疗联合化疗的理论基础及临床应用
引用本文:乔天运1,郭文文2,熊延路1,冯杨波1,周永生1,赵晋波1,姜 涛1,韩 勇1. 肿瘤免疫治疗联合化疗的理论基础及临床应用[J]. 现代肿瘤医学, 2021, 0(17): 3128-3132. DOI: DOI:10.3969/j.issn.1672-4992.2021.17.039
作者姓名:乔天运1  郭文文2  熊延路1  冯杨波1  周永生1  赵晋波1  姜 涛1  韩 勇1
作者单位:1.空军军医大学唐都医院胸腔外科,陕西 西安 710038;2.延安大学医学院,陕西 延安 716000
基金项目:National Natural Science Foundation of China(No.81772462);国家自然科学基金资助项目(编号:81772462)
摘    要:近年来,免疫疗法在肿瘤治疗中取得了重大进展,但仍只有小部分患者获益。大量基础和临床研究结果表明,恰当的免疫疗法联合化疗较单一疗法的抗肿瘤疗效更佳,成为肿瘤治疗研究新的热点。免疫疗法联合化疗能够获益的机制是多方面的,化疗除了对肿瘤细胞的直接杀伤作用,还可通过改变肿瘤细胞的免疫原性、调节免疫细胞亚群以及肿瘤微环境等机制来增强抗肿瘤免疫应答。本文就化疗对免疫应答的调节机制,以及近期的临床和临床前研究结果进行综述,阐明免疫疗法联合化疗的理论基础及临床应用前景,以期为后续的临床联合治疗提供思路和方向。

关 键 词:肿瘤免疫治疗  化疗  联合治疗  辅助治疗  新辅助治疗

Theoretical basis and clinical application of tumor immunotherapy combined with chemotherapy
QIAO Tianyun1,GUO Wenwen2,XIONG Yanlu1,FENG Yangbo1,ZHOU Yongsheng1,ZHAO Jinbo1,JIANG Tao1,HAN Yong1. Theoretical basis and clinical application of tumor immunotherapy combined with chemotherapy[J]. Journal of Modern Oncology, 2021, 0(17): 3128-3132. DOI: DOI:10.3969/j.issn.1672-4992.2021.17.039
Authors:QIAO Tianyun1  GUO Wenwen2  XIONG Yanlu1  FENG Yangbo1  ZHOU Yongsheng1  ZHAO Jinbo1  JIANG Tao1  HAN Yong1
Affiliation:1.Department of Thoracic Surgery,Tangdu Hospital,Air Force Medical University,Shaanxi Xi'an 710038,China;2.Medical College of Yan'an University,Shaanxi Yan'an 716000,China.
Abstract:In recent years,immunotherapy has made great progress in tumor treatment,but only a small number of patients have benefited.A large number of basic and clinical studies show that the anti-tumor effect of appropriate immunotherapy combined with chemotherapy is better than that of single therapy,and it has become a new focus of tumor therapy research.Immunotherapy combined with chemotherapy can benefit from many mechanisms,in addition to the direct killing effect of chemotherapy on tumor cells,it can also enhance the anti-tumor immune response by changing the immunogenicity of tumor cells,regulating immune cell subsets and tumor microenvironment.This article reviews the regulatory mechanism of chemotherapy on immune response,as well as the recent clinical and preclinical research results,and expounds the theoretical basis and clinical application prospect of immunotherapy combined with chemotherapy.In order to provide ideas and directions for follow-up clinical combination therapy.
Keywords:tumor immunotherapy   chemotherapy   combined therapy   adjuvant therapy   neoadjuvant therapy
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号